NASDAQ · SERVICES-BUSINESS SERVICES, NEC · MID CAP
Nutex Health Inc. NUTX
16 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$875.3M
▲ 82.4% vs FY2024
EPS · FY25
$10.48
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
30.7%
Net margin · FY25
8.1%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 875.3M
Revenue, FY2025 · full 16-year series below
Revenue
Net income
8 cents of every revenue dollar became profit this year.
Per share
USD 10.48
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
30.7%
Return on equity, FY2025
ROE
Operating margin31.5%
Net margin8.1%
Return on assets9.0%
Each USD of equity produced 31 cents of profit this year.
Returned to shareholders
USD 5.0M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 5.0M
Share of profit7.1%
Consecutive raises—
USD 5.0M in buybacks — 7% of the year's profit went back to shareholders.
Growth
+26.1% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+58.6%
+26.1%
+112.1%
+58.5%
Net income
−7.8%
+96.2%
+50.2%
EPS, diluted
+125.4%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.01B
Shares outstanding, FY2025
Change, 5 years+34.2%
Change, 10 years—
The share count grew 34% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 918.5M
total assets, end of FY2025
Total assetsUSD 918.5M
EquityUSD 329.4M
CashUSD 185.6M
Gross debtUSD 42.5M
Net debtUSD -143.1M
Current ratio3.41×
The company holds more cash than debt.
History
16 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.9
0.5
0.2
0.2
0.3
0.3
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
0.3
0.1
−0.0
−0.4
0.2
0.2
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
0.3
0.1
−0.0
−0.4
0.2
0.2
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
0.1
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
·
·
·
·
·
·
·
·
Net income $B
0.1
0.1
−0.0
−0.4
0.1
0.1
−0.0
−0.0
0.0
−0.0
0.0
−0.0
0.0
−0.0
−0.0
0.0
EPS, diluted $
10.48
9.69
−10.39
−100.36
0.22
0.18
−1.96
−0.56
0.01
−0.19
0.00
−0.03
0.01
−0.07
−0.02
0.01
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
30.7
53.7
−58.2
−403.6
233.6
29247.7
−3941.8
·
·
·
5.4
·
·
·
·
·
Shares out B
0.01
0.01
0.00
0.00
0.00
0.01
0.00
0.00
0.12
0.04
0.04
0.03
0.03
0.03
0.02
0.02
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
57 of 57
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed